When grafted into mice, Hcmel12 cytoLbNOX and catalytic mutant tumors demonstrated comparable time to endpoint and tumor weight at endpoint as wild-type or Mt-Nd5 mutant tumors (Extended Data Fig. 9j,k). Here, MT-ND5 is linked to neoplasm.